MLNM (Millennium Pharma)
All Pro Portfolios with MLNM
- Total Pro Portfolios with MLNM:
- Kinetics Medical MEDRX
- show more
All Do-It-Yourself Portfolios with MLNM
- Total Do-It-Yourself Portfolios with MLNM:
- PhilF
- H.F. Enger Portfolio 1
- Bio+Bank+Retail+IT
- ccsgene Portfolio 1
- Abraham Portfolio 1
- hopeful-1
- Frankin
- Michael Welborn Portfolio 1
- DWL Stocks
- garyr Portfolio 1
- menlotungsten Portfolio 1
- ibrahim123 Portfolio 1
- Medical-Related
- MMK Portfolio 1
- SUPRATRADE PANTERA II
- bhukaplan Portfolio 1
- DF
- estout Portfolio 1
- sell
- harv1015 Portfolio 1
- scjs4r Portfolio 1
- GSCORF
- IFixPCs Portfolio 1
- toomuch Retirement
- Seths Growth Fund
- Dan's Cash
- teg Portfolio 3
- Highest Short Ratio - Nasdaq
- dmkim_us Portfolio 1
- SUPRATRADE-2309071602
- pw's biotechs
- harry telian Portfolio 1
- BENITRANS GZ
- Short List
- jimmybear1 Portfolio 1
- robjay Portfolio 1
- MMD-05-05-08_END DAY
- show more
- 74
- keith Portfolio 2
- QINLEIHUANG Portfolio 1
- Susan Daluisio Portfolio 1
- ddgrowth
- elizebeth Portfolio 1
- Robert Fila Portfolio 1
- y
- Jimmy D. Portfolio 1
- motherhen
- st stock
- Things I have
- stpicker711 Portfolio 1
- ljaye Portfolio 1
- jo's portfolio
- 4-12-07
- BIOI
- Arnold
- JBCOUTURE Portfolio 1
- Bill27 Portfolio 1
- sopfhia Portfolio 1
- bishop
- tramper69 Portfolio 1
- stickytrade Portfolio 1
- Eleanor1 Portfolio 1
- BENITRANS CK
- wpgbms Portfolio 1
- SUPRATRADE "BEST OF THE BEST" (PART 2)
- MRPresti Value Stocks
- sallywillard Portfolio 1
- adelxt Portfolio 1
- PAPA'S PORTFOLIO 2
- sweng02492 Portfolio 1
- chee Portfolio 1
- golbal
- Packie's stocks
- PART 6 JPMorgan 26th Annual Healthcare Conf 1/9/08..3rd Day Reporting Companies..Nymph Take
- biz.mbaker Portfolio 1
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
Date:12 04 07 |
|
leading cancer drug |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Millennium Pharma (MLNM) was upgraded to Outperform, Cowen said. Company has more potential earnings leverage than the market is giving it credit. Velcade sales also remain strong, despite rising competition. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Millennium Pharma (MLNM) was upgraded from Neutral to Outperform, Robert Baird said. $14 price target. Market has low expectations for the company and Velcade, but new indications and JNJ's promotion should finally begin to ramp. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Upgraded by Friedman Billings from Underperform to Mkt Perform |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Downgraded by Lehman Brothers from Overweight to Equal-weight |
|
Not yet rated
Rate now:
|
|
By:fhoeffler14 |
Date:06 10 07 |
Pharmacutical company with many prospective drugs developing in the late stages. Not far from the actual market. |
|
Not yet rated
Rate now:
|
|
By:bearsltd |
Date:05 27 07 |
heading for profitability |
|
Not yet rated
Rate now:
|
|
By:Regnes |
Date:04 26 07 |
Surprise |
|
Not yet rated
Rate now:
|
|
By:LJP1165 |
Date:04 24 07 |
MUTIPLE MYLOMA DROG |
|
Not yet rated
Rate now:
|
|
By:krolland |
Date:03 15 07 |
investment letter recommendation |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
Date:02 03 07 |
|
It's just never really risen to the occassion. Always disappoints. |
|
Not yet rated
Rate now:
|
|
By:ron unger |
Date:01 03 07 |
biotech |
|
Not yet rated
Rate now:
|
|
